Annual Shareholders Equity
$17.58 B
+$3.67 B+26.36%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual stockholders equity is currently $17.58 billion, with the most recent change of +$3.67 billion (+26.36%) on 31 December 2023. During the last 3 years, it has risen by +$8.89 billion (+102.38%). VRTX annual shareholders equity is now at all-time high.VRTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$15.63 B
+$856.20 M+5.80%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly stockholders equity is currently $15.63 billion, with the most recent change of +$856.20 million (+5.80%) on 30 September 2024. Over the past year, it has dropped by -$881.90 million (-5.34%). VRTX quarterly shareholders equity is now -15.72% below its all-time high of $18.55 billion, reached on 31 March 2024.VRTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.4% | -5.3% |
| 3 y3 years | +102.4% | +64.0% |
| 5 y5 years | +296.4% | +197.5% |
VRTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +102.4% | -15.7% | +64.0% |
| 5 y | 5 years | at high | +296.4% | -15.7% | +197.5% |
| alltime | all time | at high | >+9999.0% | -15.7% | >+9999.0% |
Vertex Pharmaceuticals Incorporated Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.63 B(+5.8%) |
| June 2024 | - | $14.77 B(-20.3%) |
| Mar 2024 | - | $18.55 B(+5.5%) |
| Dec 2023 | $17.58 B(+26.4%) | $17.58 B(+6.5%) |
| Sept 2023 | - | $16.51 B(+6.7%) |
| June 2023 | - | $15.47 B(+7.2%) |
| Mar 2023 | - | $14.43 B(+3.7%) |
| Dec 2022 | $13.91 B(+37.7%) | $13.91 B(+6.8%) |
| Sept 2022 | - | $13.03 B(+9.2%) |
| June 2022 | - | $11.93 B(+9.4%) |
| Mar 2022 | - | $10.91 B(+8.0%) |
| Dec 2021 | $10.10 B(+16.3%) | $10.10 B(+6.0%) |
| Sept 2021 | - | $9.53 B(+3.6%) |
| June 2021 | - | $9.20 B(+2.4%) |
| Mar 2021 | - | $8.98 B(+3.4%) |
| Dec 2020 | $8.69 B(+42.8%) | $8.69 B(+6.8%) |
| Sept 2020 | - | $8.13 B(+8.2%) |
| June 2020 | - | $7.52 B(+16.4%) |
| Mar 2020 | - | $6.46 B(+6.2%) |
| Dec 2019 | $6.09 B(+37.2%) | $6.09 B(+15.8%) |
| Sept 2019 | - | $5.25 B(+3.6%) |
| June 2019 | - | $5.07 B(+7.3%) |
| Mar 2019 | - | $4.72 B(+6.5%) |
| Dec 2018 | $4.44 B(+118.6%) | $4.44 B(+52.6%) |
| Sept 2018 | - | $2.91 B(+8.2%) |
| June 2018 | - | $2.69 B(+11.9%) |
| Mar 2018 | - | $2.40 B(+18.4%) |
| Dec 2017 | $2.03 B(+75.4%) | $2.03 B(+13.3%) |
| Sept 2017 | - | $1.79 B(+7.2%) |
| June 2017 | - | $1.67 B(+11.4%) |
| Mar 2017 | - | $1.50 B(+29.7%) |
| Dec 2016 | $1.16 B(+23.0%) | $1.16 B(+13.2%) |
| Sept 2016 | - | $1.02 B(+4.1%) |
| June 2016 | - | $981.35 M(+2.5%) |
| Mar 2016 | - | $957.08 M(+1.8%) |
| Dec 2015 | $939.97 M(-12.6%) | $939.97 M(+1.9%) |
| Sept 2015 | - | $922.15 M(+3.0%) |
| June 2015 | - | $894.96 M(-8.3%) |
| Mar 2015 | - | $976.46 M(-9.2%) |
| Dec 2014 | $1.08 B(-20.7%) | $1.08 B(-7.0%) |
| Sept 2014 | - | $1.16 B(-1.4%) |
| June 2014 | - | $1.17 B(-4.8%) |
| Mar 2014 | - | $1.23 B(-9.3%) |
| Dec 2013 | $1.36 B(+35.8%) | $1.36 B(+7.2%) |
| Sept 2013 | - | $1.26 B(-4.4%) |
| June 2013 | - | $1.32 B(+77.2%) |
| Mar 2013 | - | $746.12 M(-25.3%) |
| Dec 2012 | $999.18 M(+27.0%) | $999.18 M(-2.8%) |
| Sept 2012 | - | $1.03 B(-1.0%) |
| June 2012 | - | $1.04 B(+11.5%) |
| Mar 2012 | - | $930.50 M(+18.3%) |
| Dec 2011 | $786.84 M(+56.1%) | $786.84 M(+35.7%) |
| Sept 2011 | - | $579.76 M(+88.5%) |
| June 2011 | - | $307.55 M(-21.5%) |
| Mar 2011 | - | $391.67 M(-22.3%) |
| Dec 2010 | $503.97 M(-54.0%) | $503.97 M(-22.5%) |
| Sept 2010 | - | $650.10 M(-21.4%) |
| June 2010 | - | $827.13 M(-16.5%) |
| Mar 2010 | - | $990.61 M(-9.6%) |
| Dec 2009 | $1.10 B(+359.0%) | $1.10 B(+80.1%) |
| Sept 2009 | - | $608.74 M(-16.5%) |
| June 2009 | - | $729.06 M(+3.1%) |
| Mar 2009 | - | $706.85 M(+195.9%) |
| Dec 2008 | $238.87 M(-12.0%) | $238.87 M(-31.7%) |
| Sept 2008 | - | $349.89 M(+45.8%) |
| June 2008 | - | $239.93 M(-21.1%) |
| Mar 2008 | - | $304.25 M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $271.30 M(-46.4%) | $271.30 M(-18.3%) |
| Sept 2007 | - | $332.04 M(-19.9%) |
| June 2007 | - | $414.58 M(-17.3%) |
| Mar 2007 | - | $501.30 M(-0.9%) |
| Dec 2006 | $505.94 M(+111.5%) | $505.94 M(-0.4%) |
| Sept 2006 | - | $507.77 M(+190.2%) |
| June 2006 | - | $175.00 M(-24.9%) |
| Mar 2006 | - | $232.91 M(-2.6%) |
| Dec 2005 | $239.18 M(+574.9%) | $239.18 M(+79.4%) |
| Sept 2005 | - | $133.31 M(+8.4%) |
| June 2005 | - | $122.96 M(-1548.1%) |
| Mar 2005 | - | -$8.49 M(-124.0%) |
| Dec 2004 | $35.44 M(-81.6%) | $35.44 M(-52.3%) |
| Sept 2004 | - | $74.32 M(-32.6%) |
| June 2004 | - | $110.29 M(-29.8%) |
| Mar 2004 | - | $157.10 M(-18.5%) |
| Dec 2003 | $192.84 M(-49.1%) | $192.84 M(-16.6%) |
| Sept 2003 | - | $231.28 M(-26.2%) |
| June 2003 | - | $313.52 M(-21.7%) |
| Mar 2003 | - | $400.27 M(+5.7%) |
| Dec 2002 | $378.58 M(-20.4%) | $378.58 M(-7.3%) |
| Sept 2002 | - | $408.21 M(-6.5%) |
| June 2002 | - | $436.68 M(-3.0%) |
| Mar 2002 | - | $450.11 M(-5.3%) |
| Dec 2001 | $475.35 M(-7.5%) | $475.35 M(-0.2%) |
| Sept 2001 | - | $476.29 M(+24.9%) |
| June 2001 | - | $381.35 M(-2.4%) |
| Mar 2001 | - | $390.71 M(-24.0%) |
| Dec 2000 | $514.01 M(+145.7%) | $514.01 M(+126.8%) |
| Sept 2000 | - | $226.60 M(+0.7%) |
| June 2000 | - | $225.11 M(+11.6%) |
| Mar 2000 | - | $201.74 M(-3.6%) |
| Dec 1999 | $209.23 M(-15.0%) | $209.23 M(+1.3%) |
| Sept 1999 | - | $206.50 M(-5.5%) |
| June 1999 | - | $218.60 M(-4.7%) |
| Mar 1999 | - | $229.50 M(-6.8%) |
| Dec 1998 | $246.20 M(-10.8%) | $246.20 M(-5.0%) |
| Sept 1998 | - | $259.10 M(-0.1%) |
| June 1998 | - | $259.30 M(-3.4%) |
| Mar 1998 | - | $268.40 M(-2.8%) |
| Dec 1997 | $276.00 M(+111.0%) | $276.00 M(-2.0%) |
| Sept 1997 | - | $281.50 M(-1.6%) |
| June 1997 | - | $286.00 M(+3.9%) |
| Mar 1997 | - | $275.20 M(+110.4%) |
| Dec 1996 | $130.80 M(+53.3%) | $130.80 M(-2.2%) |
| Sept 1996 | - | $133.70 M(+116.7%) |
| June 1996 | - | $61.70 M(-21.3%) |
| Mar 1996 | - | $78.40 M(-8.1%) |
| Dec 1995 | $85.30 M(-19.1%) | $85.30 M(-0.4%) |
| Sept 1995 | - | $85.60 M(-7.4%) |
| June 1995 | - | $92.40 M(-8.4%) |
| Mar 1995 | - | $100.90 M(-4.4%) |
| Dec 1994 | $105.50 M(+113.1%) | $105.50 M(+11.4%) |
| Sept 1994 | - | $94.70 M(-4.4%) |
| June 1994 | - | $99.10 M(-5.2%) |
| Mar 1994 | - | $104.50 M(+111.1%) |
| Dec 1993 | $49.50 M(+12.8%) | $49.50 M(+21.9%) |
| Sept 1993 | - | $40.60 M(-6.0%) |
| June 1993 | - | $43.20 M(+6.4%) |
| Mar 1993 | - | $40.60 M(-7.5%) |
| Dec 1992 | $43.90 M(-15.9%) | $43.90 M(-5.6%) |
| Sept 1992 | - | $46.50 M(-4.3%) |
| June 1992 | - | $48.60 M(-4.0%) |
| Mar 1992 | - | $50.60 M(-3.1%) |
| Dec 1991 | $52.20 M(+903.8%) | $52.20 M(+87.8%) |
| Sept 1991 | - | $27.80 M(+969.2%) |
| June 1991 | - | $2.60 M(-50.0%) |
| Dec 1990 | $5.20 M | $5.20 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual stockholders equity?
- What is the all time high annual shareholders equity for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual stockholders equity?
The current annual shareholders equity of VRTX is $17.58 B
What is the all time high annual shareholders equity for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual stockholders equity is $17.58 B
What is Vertex Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
Over the past year, VRTX annual stockholders equity has changed by +$3.67 B (+26.36%)
What is Vertex Pharmaceuticals Incorporated quarterly stockholders equity?
The current quarterly shareholders equity of VRTX is $15.63 B
What is the all time high quarterly shareholders equity for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly stockholders equity is $18.55 B
What is Vertex Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?
Over the past year, VRTX quarterly stockholders equity has changed by -$881.90 M (-5.34%)